BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Urodynamix Technologies Ltd. (URO.V) Announces Change in Directors and Officers


12/21/2010 9:09:43 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - December 20, 2010) - Urodynamix Technologies Ltd. (TSX VENTURE: URO) today announces that Dave Rankin and David Raffa have been appointed to its Board of Directors and that Pierre Leduc, Barry Allan and Tanner Philp have stepped down as directors.

Dave Rankin is co-founder and VP Business Development of Endurance Wind Power. Endurance is a rapidly growing local manufacturer of advanced wind turbines designed specifically for distributed wind power applications. Dave has an MBA from the University of Western Ontario and currently sits on the Board of three other public companies.

David Raffa is Chief Operating Officer and Partner of Lions Capital. David was previously a corporate finance lawyer specializing in the technology sector. Having retired from the practice of law to co-found Lions Capital, David currently serves as a director, officer or advisory board member of a number of private and public technology companies. David has a Bachelor of Science degree from Simon Fraser University and a Bachelor of Laws degree from Osgoode Hall Law School.

The new Board has appointed Jim Heppell Chairman of the Board and CEO; and David Raffa as President and Secretary.

"I would like to personally thank Barry Allen and Dr. Luya Li for their tenacity and hard work in closing the sale of the Company's assets for $2.1 million," said Jim Heppell. "If not for their efforts, we would not have this opportunity to rebuild shareholder value. I would also like to acknowledge Pierre Leduc who, as Chairman of the Board, led the Company during a particularly challenging time."


Contacts:
Urodynamix Technologies Ltd.
Jim Heppell
778-888-7788



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->